enVVeno Medical Corporation (NVNO)

enVVeno Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.75	3.62	4.56	54.73	9.33
Short-Term Investments	41.4	42.79	34.49	-	-
Cash & Short-Term Investments	43.15	46.41	39.04	54.73	9.33
Cash Growth	-7.02%	18.87%	-28.66%	486.29%	614.07%
Prepaid Expenses	0.58	0.51	0.39	0.31	0.23
Total Current Assets	43.73	46.92	39.44	55.04	9.57
Property, Plant & Equipment	1.19	1.68	2.19	2.61	0.94
Other Long-Term Assets	0.03	0.03	0.03	0.05	0.03
Total Assets	44.95	48.64	41.66	57.7	10.54
Accounts Payable	1.01	0.43	0.65	0.56	1.39
Accrued Expenses	0.73	0.61	0.57	0.73	0.98
Short-Term Debt	-	-	-	-	0.31
Current Portion of Leases	0.36	0.34	0.31	0.29	0.31
Other Current Liabilities	-	-	-	-	0.19
Total Current Liabilities	2.1	1.37	1.53	1.58	3.19
Long-Term Leases	0.7	1.06	1.4	1.72	0.25
Total Liabilities	2.8	2.44	2.93	3.3	3.44
Common Stock	-	-	-	-	0
Additional Paid-In Capital	194.01	176.24	145.25	136.26	72.42
Retained Earnings	-151.86	-130.04	-106.52	-81.85	-65.32
Total Common Equity	42.16	46.2	38.73	54.4	7.1
Shareholders' Equity	42.16	46.2	38.73	54.4	7.1
Total Liabilities & Equity	44.95	48.64	41.66	57.7	10.54
Total Debt	1.06	1.4	1.72	2.01	0.88
Net Cash (Debt)	42.09	45.01	37.33	52.72	8.45
Net Cash Growth	-6.49%	20.58%	-29.20%	523.64%	1776.16%
Net Cash Per Share	2.46	3.66	3.94	6.07	6.55
Filing Date Shares Outstanding	17.54	13.32	9.47	9.47	8.5
Total Common Shares Outstanding	17.54	13.32	9.47	9.47	2.54
Working Capital	41.64	45.55	37.91	53.46	6.38
Book Value Per Share	2.40	3.47	4.09	5.74	2.79
Tangible Book Value	42.16	46.2	38.73	54.4	7.1
Tangible Book Value Per Share	2.40	3.47	4.09	5.74	2.79
Machinery	1.44	1.4	1.37	0.81	0.48
Leasehold Improvements	-	-	-	0.19	0.16

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q